Literature DB >> 22310244

Outcome analysis of patients with primary breast cancer initially treated at a certified academic breast unit.

J Heil1, A Gondos, G Rauch, F Marmé, J Rom, M Golatta, H Junkermann, P Sinn, S Aulmann, J Debus, H Hof, F Schütz, H Brenner, C Sohn, A Schneeweiss.   

Abstract

INTRODUCTION: Evaluation of oncological outcome and prognostic factors of patients with primary breast cancer treated at a certified academic breast unit. PATIENTS AND METHODS: We prospectively collected data of 3338 patients, diagnosed with primary breast cancer between 01.01.2003 and 31.12.2010 and treated at the Breast Unit Heidelberg, Germany, in order to analyze outcome in clinical practice. We evaluated local control rate (LCR), disease-free survival (DFS), distant disease-free survival (DDFS), observed overall survival (OS) and age-adjusted relative overall survival (ROS). In addition, the impact of known prognostic factors on these outcome variables was examined in univariate and multivariate analyses.
RESULTS: Of all patients, 368 (11.0%) had carcinoma in situ (CIS) and 197 (5.9%) had bilateral cancers. For the 2970 patients with invasive cancer, of which 49 patients (1.7%) had metastastic disease at time of diagnosis, DFS, LCR, DDFS, OS and ROS at 5 years were 79.8%, 84.7%, 81.2%, 86.3%, and 89.8%, respectively. In multivariate analysis age, pT category, nodal status, hormone receptor status and grading were identified as independent prognostic factors for OS.
CONCLUSION: Compared with recent population-based reports from Germany, more favourable patient characteristics and nominally higher survival was found among this large cohort of patients with primary breast cancer treated at a single certified breast unit.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22310244     DOI: 10.1016/j.breast.2012.01.009

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  17 in total

1.  [Requirements for organ-specific oncology centers].

Authors:  S Wesselmann
Journal:  Urologe A       Date:  2015-10-16       Impact factor: 0.639

Review 2.  Tumour-adapted Reduction Mammoplasty - a New (Old) Breast Conserving Strategy: Review.

Authors:  M Eichbaum; A Dietrich; J Reinhard; R Steinwasser; C Eichbaum
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-01       Impact factor: 2.915

3.  Locoregional risk assessment after neoadjuvant chemotherapy in patients with primary breast cancer: clinical utility of the CPS + EG score.

Authors:  Laura L Michel; Laura Sommer; Rosa González Silos; Justo Lorenzo Bermejo; Alexandra von Au; Julia Seitz; André Hennigs; Katharina Smetanay; Michael Golatta; Jörg Heil; Florian Schütz; Christof Sohn; Andreas Schneeweiss; Frederik Marmé
Journal:  Breast Cancer Res Treat       Date:  2019-06-24       Impact factor: 4.872

4.  Should Breast Cancer Surgery Be Done in an Outpatient Setting?: Health Economics From the Perspective of Service Providers.

Authors:  Margaret Formago; Michael G Schrauder; Claudia Rauh; Carolin C Hack; Sebastian M Jud; Thomas Hildebrandt; Rüdiger Schulz-Wendtland; S Frentz; S Graubert; Matthias W Beckmann; Michael P Lux
Journal:  Geburtshilfe Frauenheilkd       Date:  2017-08-24       Impact factor: 2.915

5.  Willingness of Patients with Breast Cancer in the Adjuvant and Metastatic Setting to Use Electronic Surveys (ePRO) Depends on Sociodemographic Factors, Health-related Quality of Life, Disease Status and Computer Skills.

Authors:  J Graf; E Simoes; K Wißlicen; L Rava; C B Walter; A Hartkopf; L Keilmann; A Taran; S Wallwiener; P Fasching; S Y Brucker; M Wallwiener
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-05       Impact factor: 2.915

Review 6.  Relevance of health economics in breast cancer treatment - the view of certified breast centres and their patients.

Authors:  Michael Lux; Thomas Hildebrandt; Elke Beyer-Finkler; Mayada Bani; Christian Loehberg; Sebastian Jud; Claudia Rauh; Michael Schrauder; Peter Fasching; Matthias Beckmann
Journal:  Breast Care (Basel)       Date:  2013-03       Impact factor: 2.860

7.  Health-related Quality of Life in Metastatic and Adjuvant Breast Cancer Patients.

Authors:  M Wallwiener; E Simoes; A N Sokolov; S Y Brucker; P A Fasching; J Graf
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-10       Impact factor: 2.915

8.  Convergence with SEER database achieved by a breast cancer network: a longitudinal benchmark of 5-year relative survival.

Authors:  Christian O Jacke; Ute S Albert; Iris Reinhard; Matthias Kalder
Journal:  J Cancer Res Clin Oncol       Date:  2014-12-16       Impact factor: 4.553

9.  Time and Resources Needed to Document Patients with Breast Cancer from Primary Diagnosis to Follow-up - Results of a Single-center Study.

Authors:  M P Lux; C S Sell; P A Fasching; J Seidl-Ertel; M R Bani; M G Schrauder; S M Jud; C R Loehberg; C Rauh; A Hartmann; R Schulz-Wendtland; V Strnad; M W Beckmann
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-08       Impact factor: 2.915

Review 10.  [Certification of head and neck tumor centers by the German Cancer Society : an overview].

Authors:  A Winter; H Iro; K-D Wolff; S Wesselmann
Journal:  HNO       Date:  2013-11       Impact factor: 1.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.